As of 2025-09-18, the Intrinsic Value of Neximmune Inc (NEXI) is -405,121,000.00 USD. This NEXI valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.01 USD, the upside of Neximmune Inc is -4,051,210,000,000.00%.
Based on its market price of 0.01 USD and our intrinsic valuation, Neximmune Inc (NEXI) is overvalued by 4,051,210,000,000.00%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -405,121,000.00 - -405,121,000.00 | -405,121,000.00 | -4,051,210,000,000.00% |
| P/E | (2,865,749.10) - (3,558,476.94) | (2,855,440.65) | -28554406600.0% |
| DDM - Stable | (1,777,492.27) - (6,814,506.67) | (4,296,000.00) | -42960000100.0% |
| DDM - Multi | (4,934,899.00) - (15,069,172.54) | (7,477,540.00) | -74775400100.0% |
| Market Cap (mil) | 0.00 |
| Beta | 0.09 |
| Outstanding shares (mil) | 0.00 |
| Enterprise Value (mil) | -2.42 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.42% |
| Cost of Debt | 5.00% |
| WACC | 6.55% |